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Metformin is most commonly prescribed for the treatment of Type II diabetes, a disease 
in which the effects of insulin are desensitized leading to hyperglycemia. While the 
clinical effects of this generic drug are clearly established, the exact targets of metformin 
action remain unclear. The present study assesses the hypothesis that metformin lowers 
blood glucose through inhibition of pyruvate carboxylase, an anapleurotic enzyme 
involved in gluconeogenesis. Due to the relative low cost of metformin, it is widely 
accessible to communities around the world. Currently at 150 million per year, the 
number of users dependent on metformin for quality of life continues to rapidly increase. 
Thorough investigation of the drug and all possible targets involved in antidiabetic action 
becomes crucial. Thus, the purpose of this study is to further elucidate the mechanism of 
action for metformin, helping to further understand the adverse effects of taking the drug. 
Results of the study may help further explain conditions such as lactic acidosis, a 
common adverse effect of metformin described as painful and imparting pain of the 
extremities. The hypothesis will be addressed by measuring specific activity of purified 
bovine pyruvate carboxylase spectrophotometrically through loss of absorbance at 340nm 
following the oxidation of NADH. The design involves a series of enzyme-coupled 
assays treated with metformin above, below and near pharmacokinetically consistent 
concentrations (50-5,000 mM). All treated groups will consist of the enzyme and the 
buffer solution with metformin, while control groups will consist of the enzyme, buffer 
solution and no metformin. Activity between treated and control groups will be 
interpreted by linear rate models and analyzed through repeated measures analysis of 
variance. We expect metformin to have a significant inhibitory effect on pyruvate 
carboxylase at concentrations ranging from 200-500 µM, similar to concentrations found 
in the portal vein of the liver. 
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